Cancer Biopsy Market Share is Expected to Reach USD

The Liquid Biopsy Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2011-2022) and extends its insights into a ten-year forecast period (2024-2033).

Learn More On The Liquid Biopsy Market:

Liquid Biopsy Market Trends, Growth, Size, Share And Forecast Report 2024-2034 (thebusinessresearchcompany.com)

According to The Business Research Company’s Liquid Biopsy Global Market Report 2024, The liquid biopsy market size has grown exponentially in recent years. It will grow from $6.61 billion in 2023 to $8.64 billion in 2024 at a compound annual growth rate (CAGR) of 30.8%.  The  growth in the historic period can be attributed to advances in cancer research, non-invasiveness, personalized medicine, regulatory approvals, early cancer detection.

The liquid biopsy market size is expected to see exponential growth in the next few years. It will grow to $27.44 billion in 2028 at a compound annual growth rate (CAGR) of 33.5%.  The growth in the forecast period can be attributed to expanding applications, cancer monitoring, emerging technologies, companion diagnostics, biomarker discovery. Major trends in the forecast period include cancer detection and monitoring, therapeutic monitoring, minimal residual disease (mrd) monitoring, liquid biopsy in non-oncological applications.

Government funds for refining cancer detection drive the growth of the liquid biopsy market. Government funds help researchers in drug discovery, diagnosis, and treatment of diseases such as Cancer. For instance, in 2021, National Cancer Institute (NCI), a USA-based government agency increased its grant monies to $678,000 from $570,000 in 2020. Furthermore, in 2022, National Institute of Health (NIH), an American medical research agency was granted a fund of $46.6 billion and $6.9 billion was awarded to National Cancer Institute (NCI), an American cancer research agency, for advancing cancer research. Therefore, government funds positively impact the growth of the liquid biopsy market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=2815&type=smp

The liquid biopsy market covered in this report is segmented –

1) By Product: Assays Kits; Instruments; Services

2) By Clinical Application: Early Cancer Screening; Therapy Selection; Treatment Monitoring; Recurrence Monitoring Orthopedics

3) By End User: Reference Laboratories; Hospitals and Physician Laboratories; Academic and Research Centers

The liquid biopsy market report table of contents includes:

 

1. Executive Summary
2. Liquid Biopsy Market Characteristics
3. Liquid Biopsy Market Trends And Strategies
4. Liquid Biopsy Market – Macro Economic Scenario
5. Global Liquid Biopsy Market Size and Growth

.

.

.

31. Global Liquid Biopsy Market Competitive Benchmarking
32. Global Liquid Biopsy Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Liquid Biopsy Market
34. Liquid Biopsy Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model